Composition
- Active ingredients
- ESTROGENS, CONJUGATED SYNTHETIC B 0.45MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ESTROGENS, CONJUGATED SYNTHETIC B 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA021443-004 · Discontinued
- ESTROGENS, CONJUGATED SYNTHETIC B 0.45MG · TabletThis page
- ESTROGENS, CONJUGATED SYNTHETIC B 0.9MG · TabletNDA021443-005 · Discontinued
- ESTROGENS, CONJUGATED SYNTHETIC B 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA021443-003 · Discontinued
- ESTROGENS, CONJUGATED SYNTHETIC B 0.3MG · TabletNDA021443-001 · Discontinued
- ESTROGENS, CONJUGATED SYNTHETIC B 0.45MG · TabletNDA021609-002 · Discontinued
- ESTROGENS, CONJUGATED SYNTHETIC B 0.3MG · TabletNDA021609-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021443.
At a glance
- Brand name
- Enjuvia
- Active substance
- estrogens, conjugated synthetic b
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Aspen
- Status
- Discontinued
- FDA approval
- 10 May 2004
- Application
- NDA021443-002